Detalhe da pesquisa
1.
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.
Am J Transplant
; 22(4): 1133-1144, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910841
2.
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimus.
Transpl Infect Dis
; 24(2): e13805, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213773
3.
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
Clin Infect Dis
; 71(12): 3168-3173, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32575124
4.
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
N Engl J Med
; 377(5): 442-453, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28767349
5.
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts.
Kidney Int Rep
; 7(4): 720-731, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35497778
6.
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro.
Transplantation
; 104(8): 1574-1579, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732834
7.
Seventeen-year follow-up study on chromosomal aberrations in five victims accidentally exposed to several Gy of 60Co gamma-rays.
Radiat Environ Biophys
; 48(1): 57-65, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19005672
8.
Differential expression of matrix metalloproteinases and tissue-derived inhibitors of metalloproteinase in fetal and adult skins.
Int J Biochem Cell Biol
; 39(5): 997-1005, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409012
9.
Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity.
Transplant Direct
; 3(3): e139, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28361123
10.
Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection.
Transplantation
; 101(10): 2419-2428, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28557957
11.
Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients.
Transplantation
; 101(7): 1720-1726, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27841845
12.
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.
J Immunol Res
; 2017: 5672523, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265581
13.
Analysis of differentially expressed genes in fetal skin of scarless and scar-forming periods of gestational rats.
Chin J Traumatol
; 9(2): 94-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16533435
14.
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals.
Cell Mol Immunol
; 18(11): 2554-2556, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531555
15.
Acid fibroblast growth factor reduces rat intestinal mucosal damage caused by ischemia-reperfusion insult.
World J Gastroenterol
; 11(41): 6477-82, 2005 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16425419
16.
Exogenous acid fibroblast growth factor inhibits ischemia-reperfusion-induced damage in intestinal epithelium via regulating P53 and P21WAF-1 expression.
World J Gastroenterol
; 11(44): 6981-7, 2005 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-16437603
17.
Intravenous acid fibroblast growth factor protects intestinal mucosal cells against ischemia-reperfusion injury via regulating Bcl-2/Bax expression.
World J Gastroenterol
; 11(22): 3419-25, 2005 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15948248
18.
Ontogeny of expression of basic fibroblast growth factor and its receptors in human fetal skin.
Chin J Traumatol
; 8(6): 332-8, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16313708
19.
Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection.
Transpl Immunol
; 32(1): 9-17, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449536
20.
A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients.
Transplantation
; 99(11): 2356-63, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018350